Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -1.09% | 161.20 | 0.7% | $1110.11m | |
| MRK | Merck & Co., Inc. | 1.06% | 76.29 | 0.7% | $1019.05m | |
| PFE | Pfizer Inc. | 1.89% | 36.64 | 0.9% | $946.21m | |
| ABBV | AbbVie, Inc. | 1.33% | 107.51 | 1.9% | $816.77m | |
| LLY | Eli Lilly & Co. | 0.93% | 184.30 | 1.1% | $717.18m | |
| BMY | Bristol-Myers Squibb Co. | 1.16% | 62.63 | 1.0% | $716.73m | |
| AZN | AstraZeneca Plc | 0.89% | 49.94 | 1.2% | $452.77m | |
| GSK | GlaxoSmithKline Plc | 0.49% | 36.64 | 0.2% | $184.82m | |
| RPRX | Royalty Pharma Plc | 0.88% | 42.31 | 0.2% | $172.99m | |
| NVS | Novartis AG | 0.64% | 87.55 | 0.2% | $152.27m | |
| VTRS | Viatris, Inc. | 0.79% | 13.40 | 0.0% | $129.73m | |
| RGEN | Repligen Corp. | 0.95% | 206.10 | 6.8% | $92.14m | |
| ENTX | Entera Bio Ltd. | -5.66% | 3.50 | 0.0% | $83.80m | |
| CVAC | CureVac NV | -1.68% | 87.92 | 0.0% | $67.80m | |
| SNY | Sanofi | 0.75% | 50.77 | 0.2% | $62.88m |
Company Profile
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: hereditary angioedema (HAE) and diabetic macular edema (DME). The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello on March 26, 2004 and is headquartered in Cambridge, MA.